Enovis Corporation (ENOV)

44,61 -0,39 (-0,87 %) À la clôture : 04:00PM EDT

Enovis Corporation

2711 Centerville Road
Suite 400
Wilmington, DE 19808
United States
302 252 9160
https://www.enovis.com

Secteur(s): Industrials
Secteur d’activité: Specialty Industrial Machinery
Employés à temps plein: 6 550

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Matthew L. Trerotola	CEO & Chairman	3,35M	S.O.	1967
Mr. Phillip Benjamin Berry	Senior VP & CFO	1,08M	S.O.	1979
Ms. Patricia A. Lang	Senior VP & Chief Human Resources Officer	1,01M	S.O.	1959
Mr. Daniel A. Pryor	Executive Vice President of Strategy & Business Development	1,29M	S.O.	1968
Mr. Brady R. Shirley	Executive Advisor & Director	2,02M	S.O.	1966
Mr. John Kleckner	VP, Controller & Chief Accounting Officer	S.O.	S.O.	1977
Derek Leckow	Vice President of Investor Relations	S.O.	S.O.	S.O.
Mr. Bradley J. Tandy	Senior VP & Chief Legal Officer	S.O.	S.O.	1959
Katie Sweet	Vice President of Corporate Communication	S.O.	S.O.	S.O.
Mr. Terry Ross	Group President Prevention & Recovery	S.O.	S.O.	1970

Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Enovis Corporation en date du 1 juin 2024 est 2. Les scores principaux sont Audit : 6; Société : 3; Droits des actionnaires : 2; Compensation : 3.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.